Zurich Cantonal Bank
TNGX icon

Zurich Cantonal Bank’s Tango Therapeutics TNGX Stock Holding History

Zurich Cantonal Bank’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$874K Buy
27,974
+17,327
+163% +$428K ﹤0.01% 1622
2026
Q1 		$223K Buy
10,647
+6,180
+138% +$86K ﹤0.01% 2211
2025
Q4 		$39.6K Buy
4,467
+4,464
+148,800% +$38.5K ﹤0.01% 2446
2025
Q3 		$25 Hold
3
– – ﹤0.01% 2545
2025
Q2 		$15 Hold
3
– – ﹤0.01% 2556
2025
Q1 		$4 Sell
3
-13,491
-100% -$33.1K ﹤0.01% 2623
2024
Q4 		$41.7K Sell
13,494
-332
-2% -$1.54K ﹤0.01% 2566
2024
Q3 		$106K Hold
13,826
– – ﹤0.01% 2401
2024
Q2 		$119K Sell
13,826
-51
-0.4% -$394 ﹤0.01% 2307
2024
Q1 		$110K Sell
13,877
-25
-0.2% -$268 ﹤0.01% 2358
2023
Q4 		$138K Buy
13,902
+11,829
+571% +$103K ﹤0.01% 2288
2023
Q3 		$23.3K Sell
2,073
-685
-25% -$4.18K ﹤0.01% 2696
2023
Q2 		$9.16K Sell
2,758
-749
-21% -$2.69K ﹤0.01% 2749
2023
Q1 		$13.9K Buy
+3,507
New +$20.4K ﹤0.01% 2784

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Zurich Cantonal Bank's TNGX Position: Q2 2026 in Review

Zurich Cantonal Bank increased its Tango Therapeutics (TNGX) stake by 163% in Q2 2026, buying an estimated $428K and bringing the position to 27,974 shares worth $874K. The position accounts for ﹤0.01% of the portfolio, ranked #1622.

Zurich Cantonal Bank first reported a position in TNGX in Q1 2023 and has held it in 14 quarters since. 248 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • Zurich Cantonal Bank held 27,974 shares of Tango Therapeutics worth $874K as of Q2 2026.
  • Zurich Cantonal Bank bought 17,327 Tango Therapeutics shares in Q2 2026, an estimated $428K.
  • Tango Therapeutics made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #1622 holding.
  • Zurich Cantonal Bank first reported a position in Tango Therapeutics in Q1 2023 and has held it in 14 quarters since.
  • 248 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.